Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
CCDC97 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ZNF132 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATP11A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TBX18 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC39A14 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZBTB20 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRG2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRAF3IP3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GPLD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101929488 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
PKHD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIR1908 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SMAD5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RTP5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IGF1R - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PMCH - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GJA5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LAPTM4B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on